Bilcare Ltd
Incorporated in 1987, Bilcare Ltd. is engaged in the business of Pharmaceutical Packaging, Global Clinical Services, R&D services and Anti Counterfeit Technology (nCid).
- Market Cap ₹ 152 Cr.
- Current Price ₹ 64.4
- High / Low ₹ 95.4 / 42.5
- Stock P/E
- Book Value ₹ 178
- Dividend Yield 0.00 %
- ROCE -1.38 %
- ROE -3.89 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.36 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -44.2% over past five years.
- Promoter holding is low: 30.0%
- Company has a low return on equity of -33.3% over last 3 years.
- Company has high debtors of 247 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
753 | 727 | 401 | 331 | 315 | 286 | 258 | 240 | 212 | 304 | 430 | 14 | 18 | |
530 | 544 | 337 | 310 | 300 | 288 | 258 | 239 | 219 | 279 | 393 | 21 | 27 | |
Operating Profit | 223 | 183 | 64 | 21 | 15 | -3 | -0 | 1 | -8 | 25 | 37 | -7 | -9 |
OPM % | 30% | 25% | 16% | 6% | 5% | -1% | -0% | 0% | -4% | 8% | 9% | -51% | -51% |
6 | -27 | 30 | 4 | -106 | 74 | 260 | 6 | 38 | 67 | 43 | 515 | 530 | |
Interest | 80 | 102 | 147 | 132 | 32 | 48 | 56 | 72 | 69 | 75 | 68 | 0 | 1 |
Depreciation | 36 | 42 | 68 | 106 | 101 | 79 | 304 | 248 | 88 | 35 | 35 | 5 | 3 |
Profit before tax | 113 | 12 | -120 | -212 | -223 | -56 | -101 | -314 | -127 | -18 | -24 | 503 | 517 |
Tax % | 34% | 43% | -1% | 13% | 65% | -17% | 21% | -0% | 19% | 110% | 24% | 22% | |
75 | 7 | -121 | -184 | -78 | -66 | -80 | -315 | -102 | 2 | -18 | 391 | 402 | |
EPS in Rs | 31.75 | 2.79 | -51.59 | -78.01 | -33.22 | -28.00 | -33.95 | -133.89 | -43.46 | 0.76 | -7.55 | 165.97 | 170.67 |
Dividend Payout % | 6% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | -33% |
5 Years: | -44% |
3 Years: | -60% |
TTM: | -87% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 25% |
TTM: | -113% |
Stock Price CAGR | |
---|---|
10 Years: | 1% |
5 Years: | 20% |
3 Years: | 5% |
1 Year: | 42% |
Return on Equity | |
---|---|
10 Years: | -31% |
5 Years: | -72% |
3 Years: | -33% |
Last Year: | -4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 |
Reserves | 931 | 944 | 831 | 643 | 599 | 533 | 453 | 138 | 36 | 37 | 20 | 387 | 396 |
649 | 1,381 | 1,228 | 1,151 | 976 | 898 | 857 | 868 | 709 | 678 | 690 | 8 | 8 | |
281 | 338 | 554 | 802 | 441 | 518 | 285 | 346 | 205 | 189 | 193 | 36 | 36 | |
Total Liabilities | 1,885 | 2,687 | 2,636 | 2,621 | 2,039 | 1,973 | 1,618 | 1,375 | 973 | 928 | 927 | 454 | 464 |
575 | 637 | 1,255 | 1,217 | 1,177 | 1,147 | 844 | 594 | 506 | 473 | 446 | 16 | 14 | |
CWIP | 34 | 785 | 182 | 125 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments | 679 | 694 | 683 | 682 | 553 | 553 | 514 | 513 | 173 | 89 | 81 | 294 | 296 |
597 | 571 | 517 | 596 | 310 | 272 | 260 | 268 | 293 | 366 | 400 | 144 | 154 | |
Total Assets | 1,885 | 2,687 | 2,636 | 2,621 | 2,039 | 1,973 | 1,618 | 1,375 | 973 | 928 | 927 | 454 | 464 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
8 | 144 | 177 | -17 | 28 | 37 | 7 | 62 | 71 | -0 | 46 | 397 | |
-148 | -865 | -31 | -14 | 9 | -48 | 78 | 2 | 11 | 85 | 6 | 181 | |
98 | 726 | -153 | 23 | -35 | 6 | -87 | -60 | -83 | -82 | -55 | -571 | |
Net Cash Flow | -43 | 5 | -7 | -9 | 2 | -5 | -1 | 3 | -1 | 2 | -4 | 7 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 168 | 51 | 95 | 80 | 69 | 62 | 58 | 56 | 67 | 87 | 79 | 247 |
Inventory Days | 101 | 107 | 153 | 215 | 85 | 51 | 51 | 68 | 57 | 85 | 71 | 60 |
Days Payable | 109 | 159 | 165 | 181 | 77 | 86 | 114 | 156 | 129 | 116 | 100 | 439 |
Cash Conversion Cycle | 160 | -1 | 83 | 114 | 77 | 27 | -5 | -31 | -5 | 56 | 50 | -132 |
Working Capital Days | 170 | 130 | -12 | -105 | -225 | -321 | -75 | -163 | -98 | -0 | -4 | -641 |
ROCE % | 12% | 7% | -0% | -4% | -4% | -5% | -21% | -20% | -9% | 0% | 2% | -1% |
Documents
Announcements
- Non-Applicability Of SEBI Circular-SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26, 2018 With Respect To Fund Raising By Issuance Of Debt Securities By Large Entities 18 Apr
- Certificate Under Regulation 40(9) & (10) For The Year Ended On 31St March, 2024 18 Apr
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 17 Apr
- Compliance Certificate Under Regulation 7(3) Of SEBI (LODR), 2015 For The Year Ended 31St March, 2024 15 Apr
- Shareholder Meeting / Postal Ballot-Outcome of AGM 12 Apr
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Products & Services offered:
a) Pharma Packaging:[1]
Pharma Packaging is available in two broad categories viz., Polymer based Packaging Films and Aluminum based Packaging Foils. Their sub-categories are:
Blister Films
Blister Foils
Lidding Foils
CR Foils
Laminates
b) Global Clinical Supplies and Services:[2]
Company handles domestic and global manufacturing of IMPs and Placebos, Primary
and secondary packaging with various blinding techniques, IWRS, Storage at variable temperatures.